← Insider buys

RVNC

Revance Therapeutics, Inc.

No insider bought or sold Revance Therapeutics, Inc. in the last 12 months

$0Bought, 12 mo
$0Sold, 12 mo

RVNC over the last year

Prices for RVNC aren't in yet.

RVNC after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

63 insider filings since 2016, newest first

RVNCSell

Dustin S Sjuts · President

$46K−5.0%Mar 19
RVNCSell

Dwight Moxie · CLO and General Counsel

$41K−6.0%Mar 19
RVNCSell

Tobin Schilke · CFO

$47K−5.0%Mar 19
RVNCBuy

Mark J Foley · CEO

$209K+3.0%Mar 8
RVNCSell

Dwight Moxie · SVP, General Counsel and Secretary

$613K−44.0%Sep 7
RVNCSell

Mark J Foley · CEO

$593K−3.0%Aug 4
RVNCSell

Tobin Schilke · CFO

$43K−2.0%Jul 5
RVNCSell

Mark J Foley · CEO

$655K−3.0%Jul 5
RVNCSell

Carey Oconnor Kolaja · Director

$71K−13.0%Jun 20
RVNCSell

Dustin S Sjuts · President

$154K−3.0%Jun 13
RVNCSell

Mark J Foley · CEO

$961K−3.0%Jun 13
RVNCSell

Tobin Schilke · CFO

$98K−4.0%Jun 5
RVNCSell

Dwight Moxie · SVP, General Counsel and Secretary

$739K−24.0%May 16
RVNCSell

Tobin Schilke · CFO

$739K−20.0%May 16
RVNCSell

Mark J Foley · CEO

$2.4M−6.0%May 16
RVNCSell

Dustin S Sjuts · President

$726K−12.0%May 16
RVNCSell

Tobin Schilke · CFO

$101K−5.0%May 2
RVNCSell

Tobin Schilke · CFO

$103K−5.0%Apr 4
RVNCSell

Dwight Moxie · SVP, General Counsel and Secretary

$584K−25.0%Mar 9
RVNCSell

Tobin Schilke · CFO

$585K−20.0%Mar 9
RVNCSell

Dustin S Sjuts · President

$679K−15.0%Mar 9
RVNCSell

Mark J Foley · CEO

$2.2M−7.0%Mar 9
RVNCSell

Tobin Schilke · CFO

$107K−6.0%Mar 2
RVNCSell

Tobin Schilke · CFO

$111K−6.0%Feb 2
RVNCSell

Tobin Schilke · CFO

$31K−2.0%Jan 23
RVNCSell

Tobin Schilke · CFO

$101K−6.0%Jan 10
RVNCSell

Dwight Moxie · SVP, General Counsel and Secretary

$298K−26.0%Sep 16
RVNCSell

Dwight Moxie · SVP, General Counsel and Secretary

$50K−3.0%Sep 28
RVNCSell

Aubrey Rankin · Pres, Innovation, Tech

$247K−2.0%Aug 17
RVNCSell

Aubrey Rankin · Pres, Innovation, Tech

$1.6M−9.0%Jul 30
RVNCSell

Aubrey Rankin · Pres, Innovation, Tech

$1.6M−8.0%Jul 28
RVNCSell

Aubrey Rankin · Pres, Innovation, Tech

$842K−5.0%Mar 5
RVNCSell

Aubrey Rankin · Pres, Innovation, Tech

$859K−5.0%Feb 3
RVNCSell

Aubrey Rankin · Pres, Innovation, Tech

$921K−4.0%Jan 4
RVNCSell

Aubrey Rankin · Pres, Innovation, Tech

$790K−4.0%Dec 2
RVNCSell

Aubrey Rankin · Pres, Innovation, Tech

$866K−4.0%Oct 30
RVNCSell

Aubrey Rankin · Pres, Innovation, Tech

$867K−4.0%Sep 30
RVNCSell

L Daniel Browne · CEO and President

$180K−7.0%Mar 19
RVNCSell

L Daniel Browne · CEO and President

$96K−3.0%Feb 20
RVNCSell

Cyril Allouche · Principal Accounting Officer

$52K−32.0%Nov 9
RVNCSell

Lauren P Silvernail · CFO, CBO

$87K−4.0%May 24
RVNCSell

Lauren P Silvernail · CFO, CBO, Secretary

$106K−5.0%Mar 23
RVNCBuy

Philip J. Vickers · Director

$98K+105.0%Mar 16
RVNCSell

Phyllis Gardner · Director

$168K−64.0%Mar 16
RVNCSell

L Daniel Browne · CEO and President

$204K−4.0%Mar 16
RVNCSell

Lauren P Silvernail · CFO, CBO, Secretary

$892K−26.0%Mar 15
RVNCSell

L Daniel Browne · CEO and President

$858K−17.0%Mar 9
RVNCSell

Lauren P Silvernail · CFO, CBO, Secretary

$640K−22.0%Mar 9
RVNCSell

L Daniel Browne · CEO and President

$190K−5.0%Nov 24
RVNCBuy

Mark J Foley · Director

$539K+333.0%Nov 9

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.